Vinay Prasad, chief of the FDA’s Center for Biologics Evaluation and Research, is planning to publish a paper this month to ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

Recent technological advances have opened new possibilities for neuroscience research, allowing researchers to map the brain's structure and synaptic connectivity (i.e., the junctions via which ...

The surge in genetic disorders such as cystic fibrosis ... Future Market Insights, Inc. (ESOMAR certified, recipient of the ...

ISRO is gearing up for an ambitious seven-mission push by March 2026, including crucial uncrewed Gaganyaan flights to pave the way for human spaceflig ...

A team of scientists has developed a highly accurate blood test for Chronic Fatigue Syndrome. The test reads tiny DNA patterns that reveal the biological signature of the illness. For millions who’ve ...

A research team has developed pioneering technology that enables human kidney organoids to be produced on a scalable basis. These organoids can then be combined with pig kidneys outside the body and ...

InvestorAi's AI models empower retail investors with outperforming equity baskets, leveraging proprietary tech. CEO Bruce Keith discusses the company's growth and future plans.

The 11th edition of ETSA was part high-decibel celebration, part deep reflection on everything from quantum computing, space tech and assorted stuff from geek heaven.

According to Bloomberg News, Vinay Prasad, who oversees gene therapies at the FDA, said the plans will be published in early November. He foresees the approach sparking curiosity for the next wave of ...

The Duke Reading Center, which specializes in the analysis of retinal images, collaborated with Sina Farsiu, professor in the departments of ophthalmology and biomedical engineering, to play a pivotal ...